Trial comparisons

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=81

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT02475850-sae",
        "title": "Intervention - Fall Prevention Standard of Care vs Control: serious adverse events",
        "summary": "1139 of 2802 against 1108 of 2649; risk difference -1.2 points, 95% interval -3.8 to 1.4; NCT02475850, Strategies to Reduce Injuries and Develop Confidence in Elders",
        "record": "/library/comparisons/NCT02475850-sae",
        "nct_id": "NCT02475850",
        "kind": "serious-adverse-events",
        "participants": 5451,
        "risk_difference": {
          "value": -0.011775685220797638,
          "lower": -0.03790028765493776,
          "upper": 0.01435696491586411
        },
        "group_1": "1,139 of 2,802",
        "group_2": "1,108 of 2,649",
        "difference": "-1.2 points",
        "interval": "-3.8 to 1.4",
        "trial_title": "Strategies to Reduce Injuries and Develop Confidence in Elders"
      },
      {
        "id": "NCT02968849-deaths",
        "title": "Vaccine vs Placebo: deaths from any cause",
        "summary": "8 of 2704 against 10 of 2700; risk difference -0.1 points, 95% interval -0.4 to 0.3; NCT02968849, Pivotal Phase 2b/3 ALVAC/Bivalent gp120/MF59 HIV Vaccine Prevention Safety and Efficacy Study in South Africa",
        "record": "/library/comparisons/NCT02968849-deaths",
        "nct_id": "NCT02968849",
        "kind": "deaths",
        "participants": 5404,
        "risk_difference": {
          "value": -0.0007451238220468992,
          "lower": -0.004171944832423495,
          "upper": 0.0025848820706288636
        },
        "group_1": "8 of 2,704",
        "group_2": "10 of 2,700",
        "difference": "-0.1 points",
        "interval": "-0.4 to 0.3",
        "trial_title": "Pivotal Phase 2b/3 ALVAC/Bivalent gp120/MF59 HIV Vaccine Prevention Safety and Efficacy Study in South Africa"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=82",
  "request_id": "A_3LjnqaTCHvMBAA"
}